Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01239797 |
|---|---|
| Brief Title: | Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma (ELOQUENT - 2) |
| First Submitted : | November 8, 2010 |
| First Submitted that Met QC Criteria : | November 10, 2010 |
| First Posted : | November 11, 2010 (Estimate) |
| Results First Submitted : | August 4, 2016 |
| Results First Submitted that Met QC Criteria : | January 4, 2017 |
| Results First Posted : | January 5, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 5, 2022 |
| Last Update Posted : | June 1, 2022 |